Increase basic, translational, and clinical research in the areas of heart, vascular, and pulmonary diseases.

• Increase high-impact research in heart failure and/or the molecular basis of myocardial dysfunction.
• Increase high-impact research in regenerative medicine. These individuals would have expertise that is applicable across a broad spectrum of cardiovascular and pulmonary diseases.
• Increase high-impact research in drug development and delivery relevant to cardiovascular and pulmonary diseases.
• Increase high-impact research in molecular imaging, applicable to a wide range of cardiovascular and pulmonary diseases.

Increase high impact research related too basic, translational, and clinical components: virology, tropical and third world infectious diseases, the microbiome, drug resistance, and immunology.

• Increase high-impact research in virology.
• Increase high-impact research related to human or animal microbiomes as they relate to disease.
• Increase high-impact research in tropical diseases.
• Increase high-impact research in antibiotic/antiviral resistance.

Increase functional Core offerings at USF Health by multiple mechanisms including a fully revamped relationship with Moffitt Cancer Center (MCC).

• Acquisition of on-campus Cryogenic Electron Microscopy (EM) capacity and other structural biology instrumentation (potentially with Moffitt Cancer Center [MCC]).
• Update existing instrumentation.
• Establish a new and competitive fee structure (including MCC).

Expand USF Health MCOM research in clinical trials across the spectrum of diseases and disciplines relevant to human health.

• Increase outpatient clinical trial revenue by 100% over 5 years to ~$30M.
• Increase inpatient clinical trial revenue by 300% over 5 years to ~$10M.
• Integrate and foster relationships with USF Health and TGH (the new joint office of clinical research) and USF Health and MCC (a yet to be defined organizational structure).
• Increase trial activity in under-performing departments and divisions.
• Open a Phase 1 clinical trial unit.

Obtain open faculty positions on the tenure-earning pathway (departmentally based) to attract highly funded or promising faculty with additional large grants, or be PIs on existing or renewing grants, or to be mentored to achieve such.

• Develop a plan to open new positions for tenured or tenure-earning faculty will require return of indirect costs as occurs in all other US research-intensive allopathic medical schools.
• Increase collaboration across MCOM.